Showing 7891-7900 of 8648 results for "".
- FDA Gives Octapharma USA Green Light to Conduct Phase 3 Clinical Trial of COVID-19 Treatmenthttps://modernod.com/news/fda-gives-octapharma-usa-green-light-to-conduct-phase-3-clinical-trial-of-covid-19-treatment/2477798/The FDA has approved the investigational new drug application submitted by Octapharma USA for a phase three clinical trial on the efficacy and safety of Octagam 10% [Immune Globulin Intravenous (Human)] therapy in COVID-19 patients with severe disease progression. The primary objective of
- Mayo Clinic, CommonSpirit, and Mass General Feel Hit From COVID-19 in Q1https://modernod.com/news/mayo-clinic-commonspirit-and-mass-general-feel-hit-from-covid-19-in-q1/2477795/Major health systems the Mayo Clinic, CommonSpirit Health, and Mass General Brigham revealed the first details on how the COVID-19 pandemic is hitting them financially, with some systems reporting millions in losses, according to a FierceHealthcare
- Kubota Vision Introduces Electronic Eyeglasses to Stop Myopia in Childrenhttps://modernod.com/news/kubota-vision-introduces-electronic-eyeglasses-to-stop-myopia-in-children/2477794/Kubota Vision announced positive clinical results from myopia control tests in humans. Utilizing electronic tabletop optical projection devices that embody Kubota Glasses technology, myopically-defocused images were projected on the peripheral retina of subjects to study if progression of myopia
- Early Data Show Moderna’s COVID-19 Vaccine Generates Immune Responseshttps://modernod.com/news/first-covid-19-vaccine-tested-in-the-us-shows-promise-in-data-from-eight-people/2477791/Moderna reported positive interim data from a phase 1 study of its vaccine candidate against SARS-CoV-2, with results showing that mRNA-1273 elicited neutralizing antibody titer levels in all eight initial participants in the low- and mid-dose cohorts, reaching or exceeding levels generally seen
- BVI Expands Portfolio with New Viscoelastic; Forges Strategic Partnership with Cromahttps://modernod.com/news/bvi-expands-portfolio-with-new-viscoelastic-forges-strategic-partnership-with-croma/2477789/BVI announced it has acquired the ophthalmic viscoelastic device (OVD) assets from Austrian-based Croma. In addition to the acquisition of existing products, BVI and Croma have embarked on an R&D collaboration on additional products that will come to market. Terms of the deal were not
- Tiny Biotech Sorrento Claims It Has A Coronavirus Curehttps://modernod.com/news/tiny-biotech-sorrento-claims-it-has-a-coronavirus-cure/2477780/Tiny biotech company Sorrento Therapeutics claimed Friday its experimental coronavirus treatment is a cure for COVID-19. Meanwhile, another company said it gained authorization for a coronavirus test, according to an Investor’s Business Daily
- Trump to Name Former GlaxoSmithKline Executive to Head “Warp Speed” Coronavirus Vaccine Effort: Reportshttps://modernod.com/news/trump-to-name-former-glaxosmithkline-executive-to-head-warp-speed-coronavirus-vaccine-effort-reports/2477765/According to White House officials cited in several reports Wednesday, President Donald Trump is expected to appoint Moncef Slaoui, the former chairman of GlaxoSmithKline’s vaccines division, as chief adviser of Operation Warp Speed, an initiative aimed at speeding up the search for a coron
- House Democrats Push New Round of Stimulus Checks in Coronavirus Billhttps://modernod.com/news/house-democrats-push-new-round-of-stimulus-checks-in-coronavirus-bill/2477760/House Democratic leaders are pushing for another round of stimulus payments of up to $1,200 per person in new coronavirus relief legislation that’s headed for a vote Friday, according to an NBC News report.
- New Visionix VX65 Digital Phoropter Helps ECPs Meet Social Distancing Recommendationshttps://modernod.com/news/new-visionix-vx65-digital-phoropter-helps-ecps-meet-social-distancing-recommendations/2477756/Luneau Technology USA announced the expansion of its Visionix product line with the addition of the Visionix VX65 digital phoropter. With the majority of refractions are still being conducted with a manual phoropter, the VX65 provides a smooth transition for eye care professionals looking to init
- Regeneron CEO: Manufacturing Not Up to Snuff for COVID-19 Vaccines, Therapieshttps://modernod.com/news/regeneron-ceo-manufacturing-not-up-to-snuff-for-covid-19-vaccines-therapies/2477753/Regeneron has been at the forefront of the COVID-19 fight for months with partnered med Kevzara in clinical trials and an antibody cocktail in development. But success in the clinic means nothing if drugmakers can’t produce a therapy or vaccine fast enough—and the company’s helmsman i